patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: U.S. FDA Clears Pluristem’s IND Application for Phase II COVID-19 Study

https://finance.yahoo.com/news/u-fda-clears-pluristem-ind-100010757.html

Share
New Message
Please login to post a reply